Mucus-clear Jr. Nighttime

Dosage for Artemisia Cina Flower is highly individualized and is never a 'one-size-fits-all' regimen. For diagnostic testing, a single drop of the extract (usually 1:10 or 1:20 w/v in glycerin) is applied to the skin. For immunotherapy, the dosage follows a two-phase protocol:

1. 1Build-up Phase: This phase involves weekly or bi-weekly injections. The starting dose is extremely dilute (e.g., 0.05 mL of a 1:100,000 dilution). The dose is gradually increased by 20% to 50% at each visit, provided the patient tolerates the previous dose without a significant local or systemic reaction.
2. 2Maintenance Phase: Once the 'top dose' or 'maintenance dose' is reached (often 0.5 mL of a 1:100 or 1:20 w/v concentration), the interval between injections is increased to every 2 to 4 weeks. This phase typically continues for 3 to 5 years.

Artemisia Cina Flower extracts may be used in children, generally starting at age 5 and older. The dosing logic is identical to adult dosing (based on immunological response rather than body weight), but smaller volumes may be used initially to assess sensitivity. Pediatric patients must be monitored even more closely for signs of systemic distress, as they may not be able to articulate early symptoms of anaphylaxis as clearly as adults.

Renal Impairment

No specific dosage adjustments are required for patients with renal impairment, as the extract is not cleared primarily by the kidneys. However, the patient's overall health and ability to survive a systemic reaction should be considered.

Hepatic Impairment

No adjustments are necessary for hepatic impairment. The metabolic pathway of allergenic proteins is independent of liver enzyme systems like CYP450.

Elderly Patients

Elderly patients may have a reduced skin response to diagnostic testing (false negatives). In immunotherapy, caution is advised if the patient has underlying cardiovascular disease, as the use of epinephrine (the treatment for a severe reaction) may be riskier in this population.

Artemisia Cina Flower is never self-administered by the patient at home. It must be administered in a clinical setting (such as an allergist's office) equipped with emergency supplies.

• Skin Testing: The skin (usually the forearm or back) is cleaned. A drop of extract is placed, and a sterile lancet is used to prick the skin. Results are read exactly 15 to 20 minutes later.
• Immunotherapy Injections: The injection is given subcutaneously (under the skin, not into the muscle or vein) in the posterior aspect of the upper arm.
• Storage: Extracts must be kept refrigerated at 2°C to 8°C (36°F to 46°F). They should never be frozen.

If a dose in the build-up phase is missed, the next dose may need to be reduced depending on how much time has passed.

• 1-2 weeks late: Repeat the last dose.
• 3-4 weeks late: Reduce the dose by one or two increments.
• Over 4 weeks late: The healthcare provider may need to restart the build-up from a much lower concentration to ensure safety.

An 'overdose' in the context of allergenic extracts refers to the administration of a dose that exceeds the patient's current tolerance level. This can lead to a severe systemic allergic reaction or anaphylaxis.

• Signs: Hives, swelling of the throat, wheezing, drop in blood pressure, or rapid heart rate.
• Emergency Measures: Immediate administration of epinephrine (Adrenalin), followed by antihistamines, corticosteroids, and emergency transport to a hospital if necessary.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

The most frequent side effects associated with Artemisia Cina Flower are localized to the site of administration. These are often expected and indicate the immune system is responding to the allergen.

• Local Wheal and Flare: During skin testing, a red, itchy bump is the intended result. It usually subsides within 30 to 60 minutes.
• Injection Site Swelling: In immunotherapy, swelling (edema) at the injection site is common. If the swelling is smaller than the size of a half-dollar (approx. 3 cm), it is generally considered a normal 'local reaction.'
• Erythema (Redness): Redness around the injection site that may feel warm to the touch.
• Pruritus (Itching): Intense itching at the site of the prick or injection.

• Large Local Reactions (LLR): Swelling that exceeds 5-10 cm in diameter. This may require an adjustment in the next dose and can be treated with cold compresses and oral antihistamines.
• Delayed Local Reactions: Swelling or itching that appears 6 to 24 hours after the injection.
• Fatigue: Some patients report feeling unusually tired for a few hours following an immunotherapy session.

• Generalized Urticaria: Hives appearing on parts of the body away from the injection site.
• Rhinitis Symptoms: Sneezing, runny nose, or nasal congestion triggered by the systemic absorption of the extract.
• Vasovagal Reaction: Fainting or lightheadedness due to the needle prick or anxiety, rather than an allergic response.

> Warning: Stop taking Artemisia Cina Flower and call your doctor immediately if you experience any of these.

• Anaphylaxis: A life-threatening, multi-system allergic reaction. It can begin with a sense of 'impending doom,' followed by rapid symptoms.
• Angioedema: Deep swelling of the lips, tongue, or periorbital (around the eyes) area, which can obstruct the airway.
• Bronchospasm: Sudden constriction of the airways, causing severe wheezing and difficulty breathing.
• Hypotension: A dangerous drop in blood pressure that can lead to shock and loss of consciousness.
• Laryngeal Edema: Swelling of the larynx (voice box), making it difficult to speak or breathe.

Because Artemisia Cina Flower is an immunological agent, long-term effects are generally positive (reduction in allergy symptoms). However, prolonged use of any injectable can occasionally lead to:

• Subcutaneous Nodules: Small, firm lumps under the skin at frequent injection sites.
• Atrophy: Very rarely, localized thinning of the skin or fat tissue at the injection site.

While specific 'Black Box' labels vary by manufacturer, the FDA requires a general boxed warning for all potent allergenic extracts like Artemisia Cina Flower.

Summary of Warning: This product can cause severe, life-threatening systemic reactions, including anaphylaxis. It must only be administered by healthcare professionals in a setting equipped to treat such reactions. Patients must be observed for at least 30 minutes following every injection. Patients with unstable asthma or those taking beta-blockers may be at increased risk of severe outcomes.

Report any unusual symptoms to your healthcare provider.

Artemisia Cina Flower extract is a potent biological substance. It is not a medication for the immediate relief of symptoms but a tool for diagnosis and long-term immune modification. Patients must be in their baseline state of health (not currently experiencing an asthma flare-up or acute infection) before receiving an injection.

No FDA black box warnings for Artemisia Cina Flower specifically exist as a unique entity, but it falls under the class-wide boxed warning for Allergenic Extracts. This warning emphasizes that the product may cause anaphylaxis and should only be used by physicians experienced in such treatments. It also notes that the risk is higher in patients with highly sensitive skin or those receiving a dose increase during the build-up phase.

• Allergic Reactions / Anaphylaxis Risk: This is the primary concern. Even patients who have tolerated many previous doses can suddenly have a systemic reaction. This is why the 30-minute waiting period is mandatory.
• Asthma Status: Patients with uncontrolled or unstable asthma are at a significantly higher risk for a fatal reaction if they experience anaphylaxis. Asthma should be well-controlled (FEV1 > 80% of predicted) before any immunotherapy injection.
• Cardiovascular Disease: Patients with pre-existing heart conditions may not tolerate the physiological stress of a systemic reaction or the side effects of epinephrine if it must be administered.
• Infection/Fever: Injections should be deferred if the patient has an active infection or fever, as this can lower the threshold for a systemic reaction.

• Observation Period: A minimum 30-minute post-injection observation is required to monitor for early signs of anaphylaxis.
• Lung Function: For asthmatic patients, a peak flow meter or spirometry may be used before the injection to ensure the patient is not in a state of sub-clinical bronchospasm.
• Site Inspection: The injection site must be checked for large local reactions before the patient leaves the clinic.

Artemisia Cina Flower does not typically cause sedation. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until they have fully recovered and been cleared by a medical professional.

While alcohol does not interact directly with the extract, it can cause vasodilation (widening of blood vessels), which might theoretically increase the rate of absorption of the extract or worsen the symptoms of an allergic reaction. Patients are often advised to avoid heavy alcohol consumption on the day of their injection.

If a patient experiences a severe systemic reaction, the healthcare provider will re-evaluate the risk-benefit ratio of continuing the therapy. Unlike many drugs, there is no 'withdrawal syndrome' associated with stopping allergenic extracts, but the patient's allergy symptoms will likely return to their pre-treatment levels over time.

> Important: Discuss all your medical conditions with your healthcare provider before starting Artemisia Cina Flower.

There are no drugs that are strictly 'contraindicated' in the sense of a chemical reaction, but there are drugs that make the use of Artemisia Cina Flower dangerously unsafe:

• Beta-Blockers (e.g., Propranolol, Metoprolol): These drugs are contraindicated in many immunotherapy protocols. The reason is that beta-blockers can block the effects of epinephrine. If a patient on a beta-blocker has anaphylaxis from the Artemisia extract, the emergency treatment (epinephrine) may not work, leading to a potentially fatal outcome.

• ACE Inhibitors (e.g., Lisinopril): Some studies suggest that patients taking ACE inhibitors may be at a higher risk for more severe systemic reactions during immunotherapy, though this is less established than the beta-blocker risk.
• MAO Inhibitors (e.g., Phenelzine): These can potentiate the effects of epinephrine, leading to dangerously high blood pressure if an allergic reaction occurs and is treated.

• Antihistamines (e.g., Loratadine, Cetirizine): These drugs will suppress the 'wheal and flare' response during diagnostic skin testing, leading to false-negative results. Patients must typically stop taking antihistamines for 3 to 7 days before a skin test.
• Tricyclic Antidepressants (e.g., Amitriptyline): These also have potent antihistamine effects and can interfere with skin test accuracy.
• Corticosteroids: While low-dose inhaled steroids are usually fine, high-dose systemic steroids (like Prednisone) can dampen the immune response and interfere with both testing and the efficacy of immunotherapy.

There are no direct food interactions with the extract itself. However, patients with a known 'Pollen-Food Allergy Syndrome' (Oral Allergy Syndrome) should be cautious. If a patient is sensitive to Artemisia (mugwort/wormseed), they may experience cross-reactivity with certain foods like celery, carrots, or certain spices. Receiving an injection while also consuming these 'trigger foods' might increase the overall 'allergic load' on the body.

• St. John's Wort: No known interaction.
• Echinacea: As Echinacea is also a member of the Asteraceae family, taking it concurrently might theoretically increase the risk of a reaction in highly sensitive individuals.

Artemisia Cina Flower will not interfere with standard blood chemistry or hematology tests. However, it will directly affect:

• Allergy Blood Tests (IgE/RAST): Successful immunotherapy should eventually lead to a decrease in specific IgE levels and an increase in IgG4 levels.
• Skin Prick Tests: As mentioned, the extract is used for this test, but its therapeutic use may eventually make future skin tests less reactive.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

Artemisia Cina Flower must NEVER be used in the following circumstances:

• Previous Severe Systemic Reaction: If a patient has had a life-threatening reaction to this specific extract in the past, the risk of continuing usually outweighs any benefit.
• Uncontrolled Asthma: Patients with an FEV1 consistently below 70% of predicted or those who have had a recent hospitalization for asthma should not receive immunotherapy.
• Acute Infection: The presence of a fever or significant respiratory infection is a temporary but absolute contraindication for that day's dose.
• Beta-Blocker Therapy: Due to the inability to effectively treat anaphylaxis with epinephrine.

Conditions requiring careful risk-benefit analysis include:

• Autoimmune Diseases: There is a theoretical concern that stimulating the immune system with allergenic extracts could worsen conditions like Lupus or Rheumatoid Arthritis, though clinical evidence for this is limited.
• Malignancy: Patients with active cancer are generally not started on immunotherapy.
• Severe Atopic Dermatitis: If the skin is too inflamed, diagnostic testing may be impossible to interpret accurately.

Patients who are highly allergic to other members of the Asteraceae family (such as Ragweed, Mugwort, Dandelion, or Chamomile) are at a higher risk of reacting strongly to Artemisia Cina Flower. The healthcare provider must take a detailed history of all botanical sensitivities before proceeding.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Artemisia Cina Flower.

FDA Pregnancy Category C (or equivalent).

• Diagnostic Testing: Usually deferred during pregnancy to avoid the risk of a systemic reaction which could cause uterine contractions or fetal hypoxia (lack of oxygen).
• Immunotherapy: The general consensus is that immunotherapy should not be started during pregnancy. However, if a woman is already on a stable maintenance dose and is tolerating it well, the injections may be continued at that same dose. The dose should not be increased during pregnancy to minimize the risk of anaphylaxis.

There is no evidence that the allergenic proteins in Artemisia Cina Flower pass into breast milk in a way that would affect the infant. Immunotherapy is generally considered safe for breastfeeding mothers. However, the mother should be aware that if she has a reaction and requires medication like epinephrine or antihistamines, those medications may have their own considerations for breastfeeding.

Artemisia Cina Flower is not typically used in children under the age of 5. The primary reason is not inherent toxicity, but the difficulty of the child cooperating with the 30-minute observation period and the challenge of diagnosing systemic reactions in very young children. For children over 5, it is considered safe and effective when administered by a specialist.

In patients over 65, the primary concern is the presence of co-morbidities. Many elderly patients take beta-blockers for hypertension or have coronary artery disease. These factors increase the risk of complications from immunotherapy. Additionally, skin reactivity decreases with age, which can make diagnostic testing less reliable.

No dosage adjustment is necessary for patients with kidney disease. The proteins in the extract are not cleared by the kidneys in their active form.

No dosage adjustment is necessary for patients with liver disease. The liver's metabolic capacity does not affect the immunological processing of the allergenic extract.

> Important: Special populations require individualized medical assessment.

Artemisia Cina Flower acts as an exogenous antigen. In the diagnostic phase, it cross-links IgE antibodies on the surface of cutaneous mast cells. This triggers the release of histamine and other mediators from the mast cell granules. In the therapeutic phase, repeated exposure at increasing doses induces the production of Regulatory T-cells (Tregs). These cells secrete cytokines like IL-10 and TGF-beta, which suppress the allergic Th2 response. Furthermore, B-cells are induced to switch production from IgE to IgG4, which acts as a 'blocking antibody,' neutralizing the allergen before it can reach the IgE on mast cells.

• Onset of Action (Diagnostic): 15-20 minutes for a wheal and flare reaction.
• Onset of Action (Therapeutic): It may take 6 to 12 months of consistent immunotherapy before a patient notices a reduction in allergy symptoms.
• Duration of Effect: A completed 3-5 year course of immunotherapy can provide relief for many years, sometimes permanently, due to the 'immunological memory' of the T-regulatory cells.

| Parameter | Value |

|---|---|

| Bioavailability | Low (Subcutaneous) |

| Protein Binding | N/A (Biological Extract) |

| Half-life | Days (Proteins), Years (Immune Effect) |

| Tmax | 1-2 hours (Systemic absorption) |

| Metabolism | Proteolysis |

| Excretion | Cellular turnover |

Artemisia Cina Flower extract is a complex mixture of proteins, glycoproteins, and polysaccharides. The primary active constituents from a botanical perspective include santonin and various volatile oils, though the 'active' parts for allergy purposes are the high-molecular-weight proteins (allergens). It is typically standardized by weight/volume (w/v) or Protein Nitrogen Units (PNU) rather than a single molecular weight.

Artemisia Cina Flower is a Non-Standardized Plant Allergenic Extract. It is related to other Artemisia extracts like Artemisia vulgaris (Mugwort) and Artemisia tridentata (Sagebrush).